Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck KGaA's MS Drug Mavenclad May Defy Doubters
Aug 25 2017
•
By
Kevin Grogan
Not too late: Merck KGaA's new MS drug can still find a place in the market • Source: Shutterstock
More from New Products
More from Scrip